Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -40.40% is 43% above its 5-year average of -70.30%, near the high end of its 5-year range (-245.51%–4.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 53.81% above its 12-month average of -87.47%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -40.40%.
RETURN ON EQUITY (ROE)
-40.40%
RETURN ON EQUITY (ROE) AVG TTM
-87.47%
RETURN ON EQUITY (ROE) AVG 3Y
-47.86%
RETURN ON EQUITY (ROE) AVG 5Y
-70.30%
RETURN ON EQUITY (ROE) AVG 10Y
-101.38%
RETURN ON EQUITY (ROE) AVG 15Y
-92.81%
RETURN ON EQUITY (ROE) AVG 20Y
-107.30%
CURRENT VS TTM AVG
+53.81%
CURRENT VS 3Y AVG
+15.58%
CURRENT VS 5Y AVG
+42.53%
CURRENT VS 10Y AVG
+60.15%
CURRENT VS 15Y AVG
+56.47%
CURRENT VS 20Y AVG
+62.35%
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 390 covered companies
CURRENT VS SECTOR MEDIAN
-12.22%
vs the sector median at left
Aytu BioPharma, Inc.
Market Cap
$21.90M
Return on Equity (ROE)
-40.40%
TTM Avg
-87.47%
3Y Avg
-47.86%
5Y Avg
-70.30%
Market Cap
$20.93M
Return on Equity (ROE)
-2067.81%
TTM Avg
-13234.78%
3Y Avg
-6645.16%
5Y Avg
-6645.16%
Market Cap
$24.44M
Return on Equity (ROE)
-140.55%
TTM Avg
-62.02%
3Y Avg
-44.98%
5Y Avg
-43.41%
Market Cap
$18.82M
Return on Equity (ROE)
-117.98%
TTM Avg
-84.94%
3Y Avg
-64.05%
5Y Avg
-76.29%
Market Cap
$18.77M
Return on Equity (ROE)
N/A
TTM Avg
-3014.83%
3Y Avg
-1589.49%
5Y Avg
-1032.64%
Market Cap
$25.48M
Return on Equity (ROE)
-76.82%
TTM Avg
-235.52%
3Y Avg
-335.24%
5Y Avg
-272.42%
Market Cap
$16.58M
Return on Equity (ROE)
-101.76%
TTM Avg
-188.04%
3Y Avg
-167.76%
5Y Avg
-134.95%
Market Cap
$16.54M
Return on Equity (ROE)
N/A
TTM Avg
-416.37%
3Y Avg
-259.03%
5Y Avg
-190.00%
Market Cap
$27.31M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aytu BioPharma, Inc. (AYTU) | $21.90M | -40.40% | -87.47% | -47.86% | -70.30% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | -2067.81% | -13234.78% | -6645.16% | -6645.16% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -140.55% | -62.02% | -44.98% | -43.41% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -117.98% | -84.94% | -64.05% | -76.29% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -3014.83% | -1589.49% | -1032.64% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -76.82% | -235.52% | -335.24% | -272.42% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -101.76% | -188.04% | -167.76% | -134.95% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | N/A | -416.37% | -259.03% | -190.00% |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -111.81% | -29.10% | -257.52% | 159.26% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -271.81% | -934.34% | -347.56% | -265.02% |
ROE
-40.4%
ROA
-13.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -40.40% |
| 2026-03-31 | -96.90% |
| 2025-12-31 | -172.12% |
| 2025-09-30 | -56.41% |
| 2025-06-30 | -71.51% |
| 2025-03-31 | 4.70% |
| 2024-12-31 | -17.04% |
| 2024-09-30 | -20.95% |
| 2024-06-30 | -57.17% |
| 2024-03-31 | -44.46% |
| 2023-12-31 | -54.78% |
| 2023-09-30 | -76.07% |
| 2023-06-30 | -43.32% |
| 2023-03-31 | -75.00% |
| 2022-12-31 | -167.57% |
| 2022-09-30 | -151.43% |
| 2022-06-30 | -245.51% |
| 2022-03-31 | -182.66% |
| 2021-12-31 | -79.46% |
| 2021-09-30 | -73.39% |
| 2021-06-30 | -42.37% |
| 2021-03-31 | -29.64% |
| 2020-12-31 | -19.80% |
| 2020-09-30 | -14.27% |
| 2020-06-30 | -14.34% |
| 2020-03-31 | -29.18% |
| 2019-12-31 | -141.43% |
| 2019-06-30 | -382.80% |
| 2019-03-31 | -75.15% |
| 2018-12-31 | -52.14% |
| 2018-09-30 | -92.69% |
| 2018-06-30 | -75.89% |
| 2018-03-31 | -108.04% |
| 2017-12-31 | -533.69% |
| 2017-09-30 | -272.61% |
| 2017-06-30 | -469.97% |
| 2017-03-31 | -364.44% |
| 2016-12-31 | -316.97% |
| 2016-09-30 | -440.10% |
| 2016-06-30 | -279.42% |
| 2016-03-31 | -85.61% |
| 2015-12-31 | -62.96% |
| 2008-08-31 | -220.25% |
| 2008-05-31 | -149.49% |
| 2008-02-29 | -96.75% |
| 2007-11-30 | -88.88% |
| 2007-08-31 | -260.32% |
